Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nanostring Tech (NSTG)

Nanostring Tech (NSTG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Nanostring Tech 530 FAIRVIEW AVENUE NORTH SUITE 2000 SEATTLE WA 98109 USA

www.nanostring.com P: 206-378-6266

Description:

NanoString Technologies, Inc. is engaged in the development, manufacture and sale of life science tools. It provides nCounter Analysis System which supports research and development of clinical applications from basic discovery to the development of future molecular diagnostic tests on a single platform. The company also offers nSolver Analysis software, gene expression panels, miRNA expression assay kits, cancer copy number variation panels, nCounter leukemia fusion gene expression assay kits and human karyotype panels, custom CodeSets and master kits that are ancillary reagents, cartridges, tips and reagent plates to setup and process samples in its instruments. It markets its systems and related consumables to researchers in academic, government and biopharmaceutical laboratories primarily in North America, Europe, the Middle East and the Asia Pacific. NanoString Technologies, Inc. is headquartered in Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 5,067
Enterprise Value, $K 118,537
Shares Outstanding, K 48,118
Annual Sales, $ 127,260 K
Annual Net Income, $ -159,540 K
Last Quarter Sales, $ 48,090 K
Last Quarter Net Income, $ -37,410 K
EBIT, $ -162,590 K
EBITDA, $ -151,290 K
60-Month Beta 1.24
% of Insider Shareholders 3.10%
Float, K 46,626
% Float 96.90%
Short Volume Ratio 0.59

Growth:

1-Year Return -99.07%
3-Year Return -99.87%
5-Year Return -99.55%
5-Year Revenue Growth 10.75%
5-Year Earnings Growth -86.96%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.78 on 11/06/23
Next Earnings Date 02/27/24
Earnings Per Share ttm -3.53
EPS Growth vs. Prev Qtr 15.22%
EPS Growth vs. Prev Year 1.27%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

NSTG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -53.79%
Profit Margin % -125.37%
Debt/Equity -4.50
Price/Sales 0.03
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.06
Interest Coverage -20.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar